Lpl Financial LLC Axogen, Inc. Transaction History

Lpl Financial LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$8.38 - $17.34 $104,800 - $216,854	-12,506 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$11.18 - $18.6 $2,727 - $4,538	244 Added 1.99%	12,506 $224,000
Q3 2019 Nov 13, 2019	BUY	$12.09 - $20.46 $148,247 - $250,880	12,262 New	12,262 $153,000
Q4 2018 Feb 07, 2019	SELL	$17.09 - $38.25 $164,781 - $368,806	-9,642 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$34.05 - $55.9 $95,918 - $157,470	-2,817 Reduced 22.61%	9,642 $355,000
Q2 2018 Aug 14, 2018	BUY	$36.15 - $52.5 $25,558 - $37,117	707 Added 6.02%	12,459 $626,000
Q1 2018 May 15, 2018	BUY	$24.4 - $40.25 $3,782 - $6,238	155 Added 1.34%	11,752 $429,000
Q4 2017 Feb 14, 2018	SELL	$18.5 - $28.6 $1,831 - $2,831	-99 Reduced 0.85%	11,597 $328,000
Q2 2017 Aug 14, 2017	BUY	N/A	11,696	11,696 $196,000

163

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $541M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.